GUGGENHEIM CAPITAL LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 85 filers reported holding ACCELERON PHARMA INC in Q3 2014. The put-call ratio across all filers is 0.95 and the average weighting 1.0%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$3,451,000
+33.7%
20,052
-2.5%
0.02%
+40.0%
Q2 2021$2,581,000
-5.1%
20,565
+2.6%
0.02%
-16.7%
Q1 2021$2,719,000
+1.4%
20,049
-4.3%
0.02%
+5.9%
Q4 2020$2,682,000
-14.2%
20,960
-24.5%
0.02%
-26.1%
Q3 2020$3,126,000
-2.4%
27,775
-17.4%
0.02%
-8.0%
Q2 2020$3,202,000
+31.8%
33,611
-48.3%
0.02%
+316.7%
Q3 2017$2,429,000
+20.2%
65,051
-2.1%
0.01%
+20.0%
Q2 2017$2,020,000
+11.9%
66,474
-2.5%
0.01%0.0%
Q1 2017$1,805,000
+6.5%
68,182
+2.7%
0.01%0.0%
Q4 2016$1,695,000
+59.9%
66,406
+89.5%
0.01%
+66.7%
Q3 2014$1,060,000
-16.9%
35,038
-6.7%
0.00%0.0%
Q2 2014$1,276,00037,5520.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2014
NameSharesValueWeighting ↓
Artal Group S.A. 1,400,000$133,378,0003.73%
Foresite Capital Management III, LLC 42,030$4,004,0003.56%
KINGDON CAPITAL MANAGEMENT, L.L.C. 257,249$24,508,0002.23%
Cormorant Asset Management, LP 600,000$57,162,0002.18%
Avoro Capital Advisors LLC 1,040,000$99,081,0001.96%
QVT Financial LP 101,396$9,660,0001.64%
FARALLON CAPITAL MANAGEMENT LLC 2,100,000$200,067,0001.60%
Rhenman & Partners Asset Management AB 155,000$14,767,0001.60%
Parkman Healthcare Partners LLC 57,500$5,478,0001.54%
Ikarian Capital, LLC 187,700$17,882,0001.42%
View complete list of ACCELERON PHARMA INC shareholders